Loading...
XASX
OSX
Market cap979kUSD
Jul 10, Last price  
0.01AUD
1D
25.00%
1Q
-16.67%
IPO
-99.82%
Name

Osteopore Ltd

Chart & Performance

D1W1MN
XASX:OSX chart
P/E
P/S
0.51
EPS
Div Yield, %
Shrs. gr., 5y
92.10%
Rev. gr., 5y
15.23%
Revenues
3m
+8.74%
204,768610,620934,878414,0581,504,5781,113,0091,692,3872,217,4092,811,4433,057,098
Net income
-4m
L+11.03%
-972,768-446,975-870,249-2,382,341-1,945,886-3,620,898-4,215,598-4,871,981-3,352,436-3,722,331
CFO
-3m
L-17.19%
-184,27311,163-334,116-1,748,763-1,757,723-3,805,634-3,997,379-3,737,141-3,087,972-2,556,998

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Singapore in 2003, Osteopore Limited focuses on engineering, manufacturing, and globally commercializing bioresorbable polymer implants. These advanced devices are utilized in neurosurgical, orthopedic, and maxillofacial operations throughout Singapore, Australia, and other international regions. The company's core innovation involves employing 3D printing with bioresorbable materials to create custom, micro-structured scaffolds specifically designed to foster bone regeneration. Its product portfolio includes Osteoplug, a resorbable implant for sealing trephination burr holes during neurosurgery, and Osteomesh, another resorbable implant used in craniofacial surgery to mend various fractures, including orbital floor injuries, and to fill surgical voids. Additionally, Osteopore has forged a collaborative partnership with Livingstone Health Holding Limited to jointly pioneer new products and applications for bone and tissue regeneration.
IPO date
Sep 23, 2019
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT